Published: 01-08-2016
Review
The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review
Abstract 57 | PDF Downloads 44Page 102-111
An epidemiological perspective of the pathology and etiology of sarcoidosis
Abstract 53 | PDF Downloads 75Page 112-116
Original Articles: Clinical Research
High-resolution CT predictors of hypersensitivity pneumonitis
Abstract 50 | PDF Downloads 103Page 117-123
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids
Abstract 74 | PDF Downloads 160Page 124-129
Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases
Abstract 70 | PDF Downloads 96Page 130-138
Serum fibroblastic growth factor 23 in acute Sarcoidosis and normal kidney function
Abstract 77 | PDF Downloads 37Page 139-142
Platelet aggregability in patients with interstitial pneumonias
Abstract 53 | PDF Downloads 52Page 143-150
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
Abstract 129 | PDF Downloads 83Page 151-156
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias
Abstract 77 | PDF Downloads 58Page 157-165
Case Reports
Polishing surgical metal pieces, granulomatosis and mineralogical analysis
Abstract 69 | PDF Downloads 42Page 166-170
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Abstract 55 | PDF Downloads 68Page 171-174
Cardiac sarcoidosis – silent destroyer.
Abstract 44 | PDF Downloads 52Page 175-177
Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy
Abstract 77 | PDF Downloads 39Page 178-181
Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension
Abstract 75 | PDF Downloads 38Page 182-185
Successful management of acute respiratory failure in an Idiopathic Pulmonary Fibrosis patient using an extracorporeal carbon dioxide removal system
Abstract 72 | PDF Downloads 71Page 186-190
Letter to Editor
Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action
Abstract 89 | PDF Downloads 48Page 191-194